Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 758M | 678M | 638M | 582M |
Cost of revenue | 326M | 288M | 254M | 146M |
Gross profit | 432M | 390M | 384M | 436M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 76M | 95M | 67M | 69M |
Other operating expenses | 98M | 131M | 75M | 75M |
Operating income | 100M | 12M | 99M | 152M |
Non operating interest income | ||||
Income | 11M | 16M | 7M | 12M |
Expense | 69M | 68M | 65M | 66M |
Other income expense | 16M | -1M | -26M | -2M |
Pretax income | 49M | -51M | 9M | 94M |
Tax provision | 7M | -8M | 31M | 28M |
Net income | 42M | -43M | -22M | 66M |
Basic EPS | 0.2 | — | -0.1 | 0.2 |
Diluted EPS | 0.2 | — | -0.1 | 0.2 |
Basic average shares | 298M | — | 296M | 303M |
Diluted average shares | 298M | — | 296M | 303M |
EBITDA | 250M | 163M | 232M | 296M |
Net income from continuing op. | 42M | -43M | -22M | 66M |
Minority interests | 4M | 4M | -1M | 3M |
Preferred stock dividends | — | — | — | — |